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dysfunction and a potential prognostic factor in asymptomatic patients with AS.
However, the relation between GLS, AS severity and symptoms has not been
fully evaluated. 
 
Methods: 
 
Eighty-six patients (74±11 years, 35% female) with at least mild
AS were prospectively enrolled. Clinical evaluation included the assessment of
symptoms (angina, syncope, and dyspnea) and a physical examination. All
patients had a comprehensive transthoracic echocardiography (TTE). GLS was
measured offline using a dedicated station and software (EchoPac, General
Electric) blinded of any clinical and TTE information. 
 
Results: 
 
Forty-three patients (43%) were asymptomatic. AS range was
wide with a mean aortic valve area (AVA) of 1.06±0.42 cm
 
2
 
 [0.33-2.3] and 55
patients (64%) had a severe AS (AVA<1cm
 
2
 
). Mean EF was 63±6 and 8
patients (9%) and a reduced EF (<60%). We divided our population into 4
subgroups, asymptomatic non-severe AS (group 1), asymptomatic severe AS
and normal EF (group 2), symptomatic severe AS and normal EF (group 3)
and symptomatic severe AS and reduced EF (group 4). Overall GLS decreased
from group 1 to 4 (p<0.0001) (Table) and a correlation between AS severity
and GLS was observed (r=-0.40, p=0.0002). However, GLS was not signifi-
cantly different between patients with symptomatic and asymptomatic severe
AS (group 2 and 3, p=0.32). 
 
Conclusions: 
 
In the present study we show that GLS was significantly cor-
related to AS severity and reduced in patients impaired EF. However, GLS
was not different between patients with symptomatic and asymptomatic severe
AS. These preliminary data deserve further confirmation but raise caution
regarding the potential prognostic value of GLS in patients with asymptomatic
AS.
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Objective:
 
 Recovery of ventricular function after surgical correction of
mitral regurgitation (MR) is an important clinical issue. The best timing for
mitral valve surgery is sometimes controversial. We studied echocardiographic
characteristics of left ventricular (LV) function in 80 patients with severe
(regurgitant orifice area 
 
≥
 
 40mm
 
2
 
) and preserved ejection fraction (LV EF 
 
≥
 
60%) and compared our finding with 30 normal controls similar in age, sex
and body mass index.
 
Methods:
 
 We evaluated the controls and the organic MR patients at rest
and during a standardized exercise stress echocardiography. Patients were
imaged at rest and after 8 minutes of sub maximal exercise (heart rate [100-
120 b/m]. All the echocardiographies were prospectively performed by the
same team, the same echo-machine and protocol. It provided conventional
echocardiographic indices but also new ones like the global longitudinal
strain. 
 
Results:
 
 The LV volume were significantly larger in the MR group
(diastolic: 134± 39ml vs 69±21; p< 0.001; systolic 43±16 vs 25±9ml,
p<0.001). At rest, the EF was 68±7 % in MR group vs 65±6 in the controls
(p =0.005). E/e’ was 13±6 vs 10±2; p=0.007; the global longitudinal strain
(GLS) was 18±4% vs 21±3; p 0.001. During the exercise, the evolution of
the GLS was clearly different in the MR group versus the controls. A
slight or no increase in GLS was observed in the MR group: 19±8%. In
opposite, the control’s GLS improved: 26±3 % during the exercise;
p<0.001. If we considered GLS indexed to LV end diastolic volume, the
difference in GLS was even greatest. In comparison, exercise EF was none
significantly different between groups (MR group 72±9% vs 75±7 controls,
P=0.07). 
 
Conclusion:
 
 Independently of the LV geometry changes, GLS appears to
be a promising new index of LV systolic function in MR patients. Better than
EF, especially during an exercise, GLS performed highly better than EF dis-
tinguishing LV characteristics of patients with a significant severe MR vs.
controls. GLS might have to be tested to best select MR patients justifying an
early repair to protect LV systolic competence.
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Aims:
 
 Planimetry measured by two-dimensional transthoracic echocardio-
graphy (TTE, MVA
 
2D
 
) is the reference method for the evaluation of the severity
of mitral stenosis (MS) but is significantly less reliable when performed by non-
experienced operators and when transthoracic echogenicity is poor. Real-time
three-dimensional transoesophageal echocardiography (RT3DTEE, MVA
 
3D
 
)
may overcome those limitations but its accuracy has never been evaluated.
 
Methods: 
 
We prospectively enrolled 43 patients (59±15 years, 86%
female) referred for MS evaluation who underwent the same day a TTE and a
RT3DTEE. MVA
 
2D
 
 was assessed by experienced operators, MVA
 
3D
 
 was mea-
sured by one experienced (Level III) and one non-experienced operator (Level
I) blinded of any clinical and TTE information. RT3DTEE images were digi-
tally stored and analysed offline on a workstation using dedicated software
(QLab, Philips) in a random order. MVA
 
3D
 
 was measured at the best cross sec-
tion of the mitral valve defined as the most perpendicular and smallest orifice.
 
Results:
 
 MVA
 
3D
 
 measured by the experienced operator (1.07±0.31 cm
 
2
 
[range 0.45-1.85]) did not differ from and correlated well
with MVA
 
2D
 
 (1.08±0.32 cm
 
2
 
 [range 0.54-2.00], p=0.84, r=0.71, p<0.001), and
mean difference was small (-0.01±0.24 cm
 
2
 
). Similarly, the MVA
 
3D
 
 measured
by the non-experienced operator (1.03±0.31 cm
 
2
 
 [range 0.45-1.69]) did not
differ from and correlated well with MVA
 
2D
 
 (p=0.27, r=0.66, p<0.001; mean
difference -0.05±0.26 cm
 
2
 
). RT3DTEE intra and interobserver (between expe-
rienced and non-experienced operators) variability were respectively
0.13±0.10 cm
 
2
 
 and 0.19±0.14 cm
 
2
 
.
 
Conclusion:
 
 RT3DTEE provides accurate and reproducible MVA measure-
ments similar to 2D planimetry performed by experienced operators. Thus,
RT3DTEE should be considered as an alternative tool for the evaluation of
MS severity, especially in patients with poor echocardiographic windows or
for team less accustomed to evaluate patients with MS.
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Background:
 
 The evolution of right ventricular function in patients with
rheumatic mitral stenosis treated with balloon mitral valvuloplasty (BMV) is
not clearly defined. The aim of this study was to assess the evolution of sys-
tolic, diastolic and global function of the right ventricle (RV) immediately and
one month after BMV using a standard Doppler echocardiographic approach
combined with tissue Doppler imaging (TDI).
 
Methods:
 
 Thirty three consecutive patients (70% women; age 31±8 years;
range 19-45) with moderate to severe mitral stenosis (mitral valve area 
 
≤
 
1.5
cm
 
2
 
) in sinus rhythm who underwent successful BMV were included prospec-
tively. Echocardiographic parameters of RV function were determined before
BMV, 24 hours after BMV and one month after BMV and included pulsed
wave TDI (S velocity, isovolumic relaxation time (IVRT), Tei index), tri-
cuspid annular plane systolic excursion (TAPSE), RV fractional area change
(RVFAC), and pulmonary vascular resistance (PVR). The control group
included 14 healthy subjects (64% women, age 32±5 years; range 23-45).
 
 
Group 1 
(n=31)
Group 2 
(n=12)
Group 3
(n=35)
Group 4
(n=8)
P between 
groups
 
GLS -19,1±2.9 -18,7±4.6 -17.5±3.2 -12.5±4.0 <0.0001
